At Nucleate UK's The Forum, early stage biotech investor Nirmesh Patel of Amino Collective says there is currently a bifurcation in fundraising between biotech co's with an AI angle and those without
- Jun 4
- 1 min read
He says the mood overall in biotech is dramatically better than it has been during the previous 2-3 years, and he is unsure about whether the AI factor will continue to attract investors like generalists who have been revisiting the sector.
.png){kind=logo}